Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 6;5(3):113-21.
doi: 10.4292/wjgpt.v5.i3.113.

Use of methotrexate in inflammatory bowel disease in 2014: A User's Guide

Arun Swaminath  1 , Raja Taunk  1 , Garrett Lawlor  1
Affiliations
Review

Use of methotrexate in inflammatory bowel disease in 2014: A User's Guide

Arun Swaminath et al. World J Gastrointest Pharmacol Ther. .

Abstract

Methotrexate has been used an immunomodulator in many autoimmune diseases, including inflammatory bowel disease. However, many physicians are unfamiliar or uncomfortable with its use in the management of inflammatory bowel disease. We summarize the data for use of methotrexate in common clinical scenarios: (1) steroid dependant Crohn's disease (CD); (2) maintenance of remission in steroid free CD; (3) azathioprine failures in CD; (4) in combination therapy with Anti-TNF agents in CD; (5) decreasing antibody formation to Anti-TNF therapy in CD; (6) management of fistulizing disease in CD; and (7) as well as induction and maintenance of remission in ulcerative colitis. An easy to use algorithm is provided for the busy clinician to access and safely prescribe methotrexate for their inflammatory bowel disease patients.

Keywords: Crohn’s disease; Immunomodulators; Inflammatory bowel disease; Methotrexate; Methotrexate user’s guide; Ulcerative colitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Algorithm for evidence-based use of methotrexate in inflammatory bowel disease. AZA: Azathioprine.
See this image and copyright information in PMC

References

    1. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med. 1995;155:846–851. - PubMed
    1. Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev. 2000;(2):CD000957. - PubMed
    1. Wenzel J. Methotrexate in systemic lupus erythematosus. Lupus. 2005;14:569. - PubMed
    1. Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn’s disease: a randomised, investigator-blind study. Dig Liver Dis. 2003;35:619–627. - PubMed
    1. Oren R, Arber N, Odes S, Moshkowitz M, Keter D, Pomeranz I, Ron Y, Reisfeld I, Broide E, Lavy A, et al. Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial. Gastroenterology. 1996;110:1416–1421. - PubMed